DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $10

Wells Fargo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $8 to $10.

Benzinga · 01/22/2020 14:59

Wells Fargo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $8 to $10.